About

A seasoned team experienced in developing cancer medicines to create a fully integrated oncology company.

SMARCA2 degraders promote differentiation and inhibit proliferation in AML models

Anjana Agarwal, Koichi Ito, Olusola Peace Osinubi, KomaliVykuntam, Norman Fultang, Neha Bhagwat, Diane Heiser, Kris Vaddi, Peggy Scherle